Syndax Pharmaceuticals
SNDX
SNDX
225 hedge funds and large institutions have $1.56B invested in Syndax Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 82 increasing their positions, 72 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
14% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 72
4% more funds holding
Funds holding: 217 → 225 (+8)
0.84% less ownership
Funds ownership: 118.24% → 117.4% (-0.84%)
Holders
225
Holding in Top 10
10
Calls
$25M
Puts
$12.5M
Top Buyers
| 1 | +$32.7M | |
| 2 | +$28.9M | |
| 3 | +$21.2M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$18.6M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$14.2M |
Top Sellers
| 1 | -$28.2M | |
| 2 | -$18.2M | |
| 3 | -$15.5M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$14.3M |
| 5 |
EP
Eversept Partners
New York
|
-$9.2M |
